Uni-Bio Science Group (HK690) 联康生物科技集团 Alternatives & Competitors

12 companies similar to Uni-Bio Science Group (HK690) 联康生物科技集团 — 心创造，新医药 Leading Genuine Innovation

Gan & Lee Pharmaceuticals

Science & Excellence

379 Private Equity $46.46M

China

Biopharma Biotechnology +2

Tetra Bio-Pharma

5 Post-IPO Debt $56.80M

Ottawa, Canada

Biopharma Biotechnology +2

Arno Therapeutics Inc (ARNI)

3 Post-IPO Equity $61.40M

Biopharma Biotechnology

Targazyme

11 Series A $60.00M

Biopharma Biotechnology +2

Track all Uni-Bio Science Group (HK690) 联康生物科技集团 competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Biopharmaceutical Research Company

Developing the Next Generation of Cannabinoid Therapeutics

20 Series A $20.00M

United States

Biopharma Biotechnology

Antengene

Treating Patients Beyond Borders.

69 Series C $238.00M

Shanghai, China

Biopharma Biotechnology +2

Arpida

31 Private Equity $55.00M

Biopharma Biotechnology +2

Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...

Series A $142.00M

Biopharma Biotechnology +1

Prothya Biosolutions

Prothya Biosolutions aims to be a center of excellence in protein therapies for leading ph...

712 Private Equity

Belgium

Biopharma Biotechnology +2

Sano Genetics

Accelerating the world's transition to precision medicine.

50 $20.86M

Cambridge, United Kingdom

Biopharma Biotechnology +2

stane

Ensemble, innovons pour la santé !

46 Series A $10.00M

Lyon, France

Biopharma Biotechnology +1

Acticor Biotech

To treat the acute phase of ischemic stroke !

18 Post-IPO Equity $49.30M

Paris, France

Biopharma Biotechnology +2

About Uni-Bio Science Group (HK690) 联康生物科技集团

Uni-Bio Science Group (HK690) 联康生物科技集团 Uni-Bio Science Group Limited, listed on the main board of The Stock Exchange of Hong Kong (SEHK: 0690), focuses on R&D, manufacturing, and sales of innovative biologic products for human diseases. The company's headquarters is in Hong Kong, with main operations in mainlan...

Taxonomy

Biopharmaceuticals, R&D, Innovation, Biologic Products, Prescription Drugs, Clinical Trials, Healthcare Market, GMP-certified, Partnering, Chinese Healthcare, Patient Treatment, Medical Research, Human Health, Pharmaceutical Company

Frequently Asked Questions

Companies similar to Uni-Bio Science Group (HK690) 联康生物科技集团 include Gan & Lee Pharmaceuticals, Tetra Bio-Pharma , Arno Therapeutics Inc (ARNI), Targazyme, Biopharmaceutical Research Company. They work in Biopharma and Biotechnology and share Uni-Bio Science Group (HK690) 联康生物科技集团's focus on clinical trials, biopharmaceuticals and medical research.

Bounce Watch lists 12 companies that share Uni-Bio Science Group (HK690) 联康生物科技集团's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Uni-Bio Science Group (HK690) 联康生物科技集团 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Uni-Bio Science Group (HK690) 联康生物科技集团 Profile Tetra Bio-Pharma Alternatives Arno Therapeutics Inc (ARNI) Alternatives Targazyme Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Uni-Bio Science Group (HK690) 联康生物科技集团 on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.